Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome
Abstract Treatment of locally advanced, unresectable head and neck squamous cell carcinoma (HNSCC) often yields only modest results with radiochemotherapy (RCT) as standard of care. Prognostic features related to outcome upon RCT might be highly valuable to improve treatment. Monocarboxylate transpo...
Enregistré dans:
Auteurs principaux: | Martin Leu, J. Kitz, Y. Pilavakis, S. Hakroush, H. A. Wolff, M. Canis, S. Rieken, M. A. Schirmer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/65dee9ff75eb467db2485a259080b37c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface.
par: Marieangela C Wilson, et autres
Publié: (2013) -
Cooperative transport mechanism of human monocarboxylate transporter 2
par: Bo Zhang, et autres
Publié: (2020) -
Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters
par: Linda S. Forero-Quintero, et autres
Publié: (2017) -
Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
par: Philipp Baumeister, et autres
Publié: (2021) -
Regulation of monocarboxylic acid transporter-1 by cAMP dependent vesicular trafficking in brain microvascular endothelial cells.
par: Amy L Uhernik, et autres
Publié: (2014)